The basic document structure as per IMDRF
Section | Description of Evidence |
---|---|
Section 1: Executive Summary & Device Description | Regional regulatory overview, Device description inclduing but not limited to product specification |
Section 2: Information Supplied by Manufacturer with Device | Documentation provided with the device for users which includes but not limited to User Manual, brohures, catalogues, promotional material, warranty card |
Section 3: Designs & Manufacturing | Details on device design and manufacturing processes which includes whole design and development file, transfer checklist, manufacturing specification, process and master lot quality data, critical component lists and specifications |
Section 4: Safety Checklist | Safety and Performance Requirements checklist as per the applied regulatory body |
Section 5: Risk Management File | Assessment of device risks and risk management strategies which includes a Complete Risk Management File and methodologies to collect and identify subsequent risks throughout the device life cycle. |
Section 6: Verification and Validation | Testing and validation activities to ensure device performance which includes real time evidence |
PMS & PMPF/PMCF | Post-Market Surveillance and Post-Market Clinical Follow-up |
Clinical Evaluation | Evaluation of clinical data supporting device safety and performance, Clinical Evaluation report |
Quality Plan & Assurance | Quality management system documentation and assurance measures, Stability Study Data, Biocompatibility Data, Clinical Evidence, |
Common Specifications as per Applicable Standards | Specifications conforming to applicable standards |
The whole Technical Dossier is divided in to Six section aiming to put together pertinent data with evidences. By systematically addressing key aspects such as device description, manufacturing processes, risk management, verification, validation, and post-market surveillance, the dossier aims to demonstrate compliance with regulatory requirements and ensure the device's safety, quality, and efficacy. Through this structured approach, manufacturers can effectively navigate the regulatory landscape, facilitate the review process, and ultimately obtain the necessary approvals for market authorization.
Evidences Required and their applicability
Section |
Evidences Required |
Responsible Entity |
Conditions |
Significance |
Executive Summary & Device Description |
Regulatory Overview and overall approvals |
Manufacturer |
During initial submission to regulatory authorities |
Demonstrates compliance with regional regulatory requirements and standards |
|
Device Description, Product Specification |
Manufacturer |
During initial submission to regulatory authorities |
|
Information Supplied by Manufacturer |
Instructions for Use (IFU), Label, Implant Card, Brochures, Training Manual |
Manufacturer |
Before product distribution and marketing |
Provides clear guidance on device usage, storage, and handling, additional information such as warnings and contraindications |
Designs & Manufacturing |
Design Development File, Transfer Checklist, Approved Design Copy, Design Validation Records |
Manufacturer |
During product development and manufacturing |
Records design inputs, outputs, reviews, and changes throughout lifecycle |
|
Manufacturing Processes |
Manufacturer |
During product development and manufacturing |
|
Safety and Performance Requirements (As per Applied Country) |
Manufacturer |
Throughout product lifecycle |
Addresses identified hazards and mitigating actions |
|
Technical Documentation/Dossier |
Manufacturer |
During regulatory submissions |
||
Verification and Validation |
Software Verification, Design Verification, |
Manufacturer |
During product development and testing |
Demonstrates compliance with design specifications |
Stability Studies, Biocompatibility Studies (In-vitro and In-vivo) |
Manufacturer |
During product development and testing |
Validates device performance under intended use conditions |
|
Post-Market Surveillance (PMS) and Post-Market Clinical Follow-up (PMCF) |
PMS Plan & Reports |
Manufacturer |
Post-market product surveillance |
Collects data on device performance and safety over time |
PMCF Studies |
Manufacturer |
Post-market product surveillance |
Evaluates long-term device safety and performance |
|
Clinical Evaluation |
Clinical Evaluation Reports |
Manufacturer |
During regulatory submissions |
Summarizes clinical data supporting device safety and efficacy |
Quality Plan & Assurance |
Quality Management System (QMS) Documentation |
Manufacturer |
During product development and manufacturing |
Ensures consistent product quality and regulatory compliance |
Specifications |
Manufacturer |
During product development and testing |
Demonstrates compliance with applicable harmonized standards |
Requirements for Suppliers of Medical Devices and Materials used to Manufacture Medical Devices
* The Manufacturer is the company indicated on the ready-for-sale medical device or as applicable Definition in the regulatory jurisdiction.
** The Supplier provides the manufacturer with medical devices or materials required for the production of such devices. The supplier’s obligations and responsibilities are set out in this confirmation, supply and purchasing agreements, contracts and statutory provisions.
- Compliance with Regulatory Standards: Suppliers must adhere to all relevant regulatory standards and requirements applicable to their products. This includes obtaining necessary certifications and approvals from regulatory authorities.
- Quality Management System: Suppliers should have robust quality management systems in place to ensure consistency and reliability in their products. This includes implementing quality control measures, conducting regular audits, and maintaining documentation of processes and procedures.
- Product Specifications: Manufacturers must provide clear specifications to their suppliers regarding the materials and components required for the manufacture of medical devices. Suppliers should ensure that their products meet these specifications and are suitable for use in medical devices.
- Traceability and Documentation: Suppliers should maintain detailed records of their products, including traceability information such as batch numbers, lot codes, and expiration dates. This documentation is essential for tracking and identifying any issues that may arise during manufacturing or post-market surveillance.
- Risk Management: Suppliers should conduct risk assessments for their products and processes to identify and mitigate any potential risks to patient safety or product efficacy. This includes assessing risks related to materials composition, manufacturing processes, and supply chain disruptions.
Type of Materials which Requires the Obligations
Category | Requirements |
---|---|
Material-related | - Intentional / unintentional use |
requirements | - Nanomaterials |
- Hazardous substances | |
- Biocompatible materials | |
- Drug-free, non-DEHP, latex-free materials | |
- Materials of animal origin | |
Obligations | - Information obligation (Change) |
- Reporting obligation (Vigilance) | |
- Traceability | |
- Consent to external audits | |
- Personnel qualification | |
- Liability |